James Paul Pirruccello, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aortic Aneurysm | 4 | 2022 | 668 | 1.130 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2022 | 816 | 1.090 |
Why?
|
Hospital Records | 1 | 2017 | 95 | 0.630 |
Why?
|
Models, Cardiovascular | 1 | 2022 | 1004 | 0.630 |
Why?
|
Asymptomatic Diseases | 1 | 2020 | 577 | 0.610 |
Why?
|
Aorta | 4 | 2022 | 2118 | 0.610 |
Why?
|
Aortic Aneurysm, Thoracic | 4 | 2022 | 624 | 0.600 |
Why?
|
Aorta, Thoracic | 1 | 2021 | 1038 | 0.560 |
Why?
|
Lipid Metabolism Disorders | 1 | 2010 | 24 | 0.390 |
Why?
|
Genome-Wide Association Study | 14 | 2022 | 11907 | 0.380 |
Why?
|
Menopause, Premature | 2 | 2020 | 126 | 0.370 |
Why?
|
Lipids | 4 | 2021 | 3263 | 0.320 |
Why?
|
Genetic Variation | 4 | 2022 | 6658 | 0.320 |
Why?
|
Atrial Fibrillation | 5 | 2022 | 4515 | 0.300 |
Why?
|
Heart Defects, Congenital | 1 | 2022 | 4258 | 0.290 |
Why?
|
Inpatients | 1 | 2017 | 2242 | 0.290 |
Why?
|
Pharmacogenetics | 1 | 2010 | 699 | 0.280 |
Why?
|
Cardiovascular Diseases | 8 | 2023 | 14326 | 0.270 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 8998 | 0.260 |
Why?
|
Referral and Consultation | 1 | 2017 | 3463 | 0.250 |
Why?
|
Heart Failure | 4 | 2022 | 10123 | 0.250 |
Why?
|
Ventricular Remodeling | 2 | 2022 | 1269 | 0.240 |
Why?
|
Polymorphism, Single Nucleotide | 13 | 2022 | 15584 | 0.240 |
Why?
|
Myocardial Infarction | 4 | 2023 | 11402 | 0.230 |
Why?
|
Heart | 3 | 2022 | 4326 | 0.230 |
Why?
|
Hypobetalipoproteinemias | 2 | 2013 | 29 | 0.220 |
Why?
|
Body Weights and Measures | 1 | 2022 | 218 | 0.220 |
Why?
|
Biological Specimen Banks | 6 | 2022 | 651 | 0.220 |
Why?
|
Apolipoproteins B | 2 | 2013 | 421 | 0.200 |
Why?
|
Cholesterol, LDL | 7 | 2017 | 2371 | 0.200 |
Why?
|
Aortic Coarctation | 1 | 2022 | 266 | 0.200 |
Why?
|
Codon, Nonsense | 2 | 2013 | 292 | 0.200 |
Why?
|
Endophenotypes | 1 | 2022 | 251 | 0.200 |
Why?
|
Magnetic Resonance Imaging | 3 | 2022 | 34394 | 0.190 |
Why?
|
Heart Ventricles | 3 | 2022 | 3835 | 0.190 |
Why?
|
Aneurysm | 1 | 2022 | 325 | 0.190 |
Why?
|
Coronary Artery Disease | 5 | 2023 | 6301 | 0.180 |
Why?
|
Pneumonia | 2 | 2021 | 2094 | 0.180 |
Why?
|
Chromosomes, Human, X | 1 | 2021 | 311 | 0.180 |
Why?
|
Cholesterol, HDL | 7 | 2017 | 1839 | 0.180 |
Why?
|
Coronary Vessel Anomalies | 1 | 2022 | 312 | 0.180 |
Why?
|
Stroke Volume | 2 | 2022 | 4570 | 0.170 |
Why?
|
Receptors, Interleukin-6 | 1 | 2019 | 225 | 0.170 |
Why?
|
Long QT Syndrome | 1 | 2022 | 416 | 0.170 |
Why?
|
Ventricular Function, Right | 1 | 2022 | 580 | 0.170 |
Why?
|
Genetic Predisposition to Disease | 8 | 2022 | 17395 | 0.160 |
Why?
|
Electrocardiography | 2 | 2021 | 6403 | 0.160 |
Why?
|
Lipoprotein(a) | 1 | 2020 | 388 | 0.150 |
Why?
|
Aortic Diseases | 1 | 2022 | 723 | 0.150 |
Why?
|
Humans | 45 | 2023 | 715124 | 0.150 |
Why?
|
Atherosclerosis | 2 | 2023 | 3256 | 0.150 |
Why?
|
Middle Aged | 20 | 2023 | 214871 | 0.150 |
Why?
|
Mendelian Randomization Analysis | 3 | 2021 | 890 | 0.140 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2021 | 861 | 0.140 |
Why?
|
Carotid Artery Diseases | 1 | 2022 | 916 | 0.140 |
Why?
|
Lipoproteins, LDL | 2 | 2016 | 663 | 0.140 |
Why?
|
HLA Antigens | 1 | 2021 | 1551 | 0.130 |
Why?
|
Triglycerides | 4 | 2017 | 2589 | 0.130 |
Why?
|
Quantitative Trait Loci | 1 | 2021 | 1979 | 0.120 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2022 | 1188 | 0.120 |
Why?
|
Communicable Diseases | 1 | 2021 | 796 | 0.120 |
Why?
|
Vascular Diseases | 1 | 2022 | 1155 | 0.120 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2022 | 10980 | 0.120 |
Why?
|
Female | 24 | 2023 | 377334 | 0.110 |
Why?
|
Menopause | 1 | 2020 | 1534 | 0.110 |
Why?
|
Aged | 12 | 2022 | 162674 | 0.110 |
Why?
|
Multifactorial Inheritance | 1 | 2019 | 1148 | 0.110 |
Why?
|
Osteoporosis | 1 | 2021 | 1562 | 0.110 |
Why?
|
Postmenopause | 1 | 2020 | 2420 | 0.110 |
Why?
|
Lipoproteins, HDL | 1 | 2016 | 652 | 0.100 |
Why?
|
Male | 20 | 2022 | 351081 | 0.100 |
Why?
|
Cardiomyopathies | 1 | 2022 | 1829 | 0.100 |
Why?
|
Angiopoietins | 1 | 2010 | 89 | 0.100 |
Why?
|
Aortic Valve Stenosis | 1 | 2022 | 1834 | 0.100 |
Why?
|
Kidney Diseases | 1 | 2021 | 2128 | 0.100 |
Why?
|
Longitudinal Studies | 2 | 2023 | 13573 | 0.090 |
Why?
|
Echocardiography | 1 | 2022 | 5098 | 0.090 |
Why?
|
Interleukin-6 | 1 | 2019 | 3215 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2021 | 1729 | 0.090 |
Why?
|
Heart Diseases | 1 | 2022 | 2763 | 0.090 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2010 | 327 | 0.090 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 3130 | 0.080 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2010 | 679 | 0.080 |
Why?
|
Health Status | 1 | 2021 | 4021 | 0.080 |
Why?
|
Sepsis | 1 | 2021 | 2474 | 0.080 |
Why?
|
Fatty Liver | 1 | 2013 | 720 | 0.080 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2012 | 366 | 0.080 |
Why?
|
Genetic Loci | 2 | 2021 | 2614 | 0.080 |
Why?
|
Myocardium | 1 | 2020 | 4938 | 0.070 |
Why?
|
Genetic Association Studies | 2 | 2021 | 2720 | 0.070 |
Why?
|
Blood Glucose | 1 | 2021 | 6293 | 0.070 |
Why?
|
Predictive Value of Tests | 1 | 2022 | 15258 | 0.070 |
Why?
|
Adult | 10 | 2022 | 212129 | 0.070 |
Why?
|
Adiponectin | 1 | 2012 | 1082 | 0.070 |
Why?
|
Sequence Analysis, DNA | 3 | 2016 | 4910 | 0.070 |
Why?
|
Incidence | 3 | 2020 | 20596 | 0.070 |
Why?
|
Proteins | 1 | 2021 | 6163 | 0.070 |
Why?
|
Liver | 3 | 2017 | 7647 | 0.070 |
Why?
|
Phenotype | 6 | 2022 | 16371 | 0.070 |
Why?
|
Primary Prevention | 2 | 2023 | 1151 | 0.060 |
Why?
|
Massachusetts | 1 | 2017 | 8734 | 0.060 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7722 | 0.060 |
Why?
|
Diet | 1 | 2021 | 7582 | 0.060 |
Why?
|
RNA, Nuclear | 1 | 2022 | 27 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39285 | 0.060 |
Why?
|
Nuclear Localization Signals | 1 | 2022 | 84 | 0.060 |
Why?
|
Fibrillar Collagens | 1 | 2022 | 40 | 0.060 |
Why?
|
Aging | 1 | 2021 | 8368 | 0.060 |
Why?
|
Retrospective Studies | 2 | 2022 | 72255 | 0.050 |
Why?
|
Genotype | 4 | 2021 | 12921 | 0.050 |
Why?
|
Actinin | 1 | 2022 | 163 | 0.050 |
Why?
|
Lamin Type A | 1 | 2022 | 172 | 0.050 |
Why?
|
Risk Factors | 7 | 2023 | 70704 | 0.050 |
Why?
|
Serine Endopeptidases | 2 | 2021 | 1133 | 0.050 |
Why?
|
Lipid Metabolism | 1 | 2010 | 2003 | 0.050 |
Why?
|
Prospective Studies | 6 | 2021 | 51181 | 0.050 |
Why?
|
Hypertension | 1 | 2020 | 8247 | 0.050 |
Why?
|
Subcutaneous Tissue | 1 | 2021 | 145 | 0.050 |
Why?
|
Alendronate | 1 | 2021 | 175 | 0.050 |
Why?
|
Digestive System Diseases | 1 | 2021 | 142 | 0.050 |
Why?
|
Pedigree | 3 | 2013 | 4722 | 0.050 |
Why?
|
Stroke | 1 | 2022 | 9457 | 0.050 |
Why?
|
Genetic Pleiotropy | 1 | 2021 | 180 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2010 | 4352 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20398 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2022 | 1034 | 0.040 |
Why?
|
Urogenital Abnormalities | 1 | 2021 | 247 | 0.040 |
Why?
|
Virulence | 1 | 2022 | 1333 | 0.040 |
Why?
|
Databases, Genetic | 2 | 2019 | 1799 | 0.040 |
Why?
|
Mosaicism | 1 | 2021 | 451 | 0.040 |
Why?
|
Penetrance | 1 | 2019 | 359 | 0.040 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2022 | 735 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2013 | 4091 | 0.040 |
Why?
|
Osteoclasts | 1 | 2021 | 747 | 0.040 |
Why?
|
Eye Proteins | 1 | 2021 | 664 | 0.040 |
Why?
|
Apolipoprotein B-100 | 1 | 2017 | 171 | 0.040 |
Why?
|
Interleukins | 1 | 2021 | 802 | 0.040 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 2017 | 123 | 0.040 |
Why?
|
Hep G2 Cells | 1 | 2017 | 393 | 0.040 |
Why?
|
Prediabetic State | 1 | 2021 | 466 | 0.040 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2022 | 1621 | 0.040 |
Why?
|
Linkage Disequilibrium | 1 | 2021 | 2066 | 0.040 |
Why?
|
Genetic Linkage | 2 | 2012 | 2516 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2022 | 1785 | 0.030 |
Why?
|
Age of Onset | 1 | 2022 | 3333 | 0.030 |
Why?
|
Organ Size | 1 | 2020 | 2313 | 0.030 |
Why?
|
Receptors, LDL | 1 | 2017 | 543 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2022 | 1996 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 1822 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2027 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2020 | 1509 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2021 | 15260 | 0.030 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2020 | 934 | 0.030 |
Why?
|
Europe | 2 | 2010 | 3345 | 0.030 |
Why?
|
Quality Control | 1 | 2016 | 869 | 0.030 |
Why?
|
Cohort Studies | 4 | 2023 | 39804 | 0.030 |
Why?
|
Cost of Illness | 1 | 2022 | 1840 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 1899 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1831 | 0.030 |
Why?
|
Proprotein Convertases | 1 | 2012 | 98 | 0.030 |
Why?
|
African Americans | 3 | 2012 | 5065 | 0.030 |
Why?
|
Women's Health | 1 | 2020 | 1934 | 0.030 |
Why?
|
Waist-Hip Ratio | 1 | 2012 | 523 | 0.020 |
Why?
|
N-Acetylgalactosaminyltransferases | 1 | 2010 | 71 | 0.020 |
Why?
|
Lipase | 1 | 2012 | 310 | 0.020 |
Why?
|
Protein Phosphatase 1 | 1 | 2010 | 145 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2019 | 2018 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 2021 | 1699 | 0.020 |
Why?
|
Risk Assessment | 2 | 2023 | 23511 | 0.020 |
Why?
|
Exons | 1 | 2016 | 2476 | 0.020 |
Why?
|
Down-Regulation | 1 | 2017 | 3091 | 0.020 |
Why?
|
Lipoproteins, VLDL | 1 | 2010 | 229 | 0.020 |
Why?
|
United States | 3 | 2022 | 67665 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2022 | 3422 | 0.020 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2010 | 293 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2012 | 1160 | 0.020 |
Why?
|
Young Adult | 3 | 2023 | 56155 | 0.020 |
Why?
|
DNA | 1 | 2022 | 7159 | 0.020 |
Why?
|
RNA Interference | 1 | 2017 | 3022 | 0.020 |
Why?
|
Animals | 5 | 2022 | 170726 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2022 | 5125 | 0.020 |
Why?
|
Family Health | 1 | 2013 | 1287 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 12425 | 0.020 |
Why?
|
Obesity | 2 | 2022 | 12192 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4595 | 0.020 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2021 | 1981 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2016 | 4824 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2012 | 820 | 0.020 |
Why?
|
Mutation | 1 | 2012 | 29442 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5333 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2022 | 4230 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2010 | 1725 | 0.020 |
Why?
|
Gene Frequency | 1 | 2012 | 3713 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12404 | 0.020 |
Why?
|
Blood Pressure | 1 | 2020 | 8566 | 0.020 |
Why?
|
Prevalence | 1 | 2021 | 14869 | 0.020 |
Why?
|
Mice | 3 | 2022 | 80995 | 0.020 |
Why?
|
Body Mass Index | 1 | 2022 | 12488 | 0.020 |
Why?
|
Cholesterol | 1 | 2013 | 2896 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2021 | 11746 | 0.020 |
Why?
|
Haplotypes | 1 | 2010 | 2882 | 0.020 |
Why?
|
Hepatocytes | 1 | 2010 | 1249 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2010 | 4311 | 0.010 |
Why?
|
Binding Sites | 1 | 2010 | 6289 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29168 | 0.010 |
Why?
|
Genetic Testing | 1 | 2012 | 3319 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22936 | 0.010 |
Why?
|
Gene Expression | 1 | 2012 | 8010 | 0.010 |
Why?
|
Base Sequence | 1 | 2010 | 13315 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 41081 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2012 | 3890 | 0.010 |
Why?
|
Pilot Projects | 1 | 2010 | 8042 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23973 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2010 | 7947 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 58505 | 0.010 |
Why?
|
Research Design | 1 | 2010 | 5876 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2012 | 21790 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2010 | 20101 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 84999 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2010 | 19499 | 0.010 |
Why?
|